Basic Information
SEEKYO is a private biotechnology company dedicated to developing next-generation chemotherapies that provide effective treatment options for cancer patients without adverse effects. SEEKYO is designing intelligent drugs capable of selectively targeting the microenvironment of solid tumors while preserving healthy tissue.
SEEKYO Therapeutics
France
less than 15 people
January 01, 2018
contact@seekyo-therapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios

